We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$518B
AUM Growth
+$24.3B
Cap. Flow
-$1.52B
Cap. Flow %
-0.29%
Top 10 Hldgs %
29.53%
Holding
15,731
New
1,614
Increased
6,434
Reduced
5,866
Closed
1,610

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$555M
2
C icon
Citigroup
C
+$407M
3
MDT icon
Medtronic
MDT
+$401M
4
CMG icon
Chipotle Mexican Grill
CMG
+$392M
5
GILD icon
Gilead Sciences
GILD
+$362M

Sector Composition

Rank Sector Weight
1 Technology 3.02%
2 Healthcare 2.92%
3 Consumer Discretionary 2.17%
4 Financials 2.1%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYRS
11226
CALL
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$87.3K ﹤0.01%
40,600
+30,200
+290% +$108K
OEC icon
11227
PUT
Orion
OEC
$364M
$87.3K ﹤0.01%
4,900
+3,700
+308% +$71.3K
KRON
11228
DELISTED
Kronos Bio
KRON
$87.2K ﹤0.01%
87,201
-140,660
-62% -$156K
MMI icon
11229
PUT
Marcus & Millichap
MMI
$1.2B
$87.2K ﹤0.01%
2,200
DSI icon
11230
PUT
iShares MSCI KLD 400 Social ETF
DSI
$5.58B
$87K ﹤0.01%
800
+100
+14% +$10.5K
SBSI icon
11231
PUT
Southside Bancshares
SBSI
$986M
$86.9K ﹤0.01%
2,600
-4,600
-64% -$147K
BF.B icon
11232
Brown-Forman Class B
BF.B
$13B
$86.8K ﹤0.01%
+1,765
New +$79.4K
GGB icon
11233
PUT
Gerdau
GGB
$9.3B
$86.8K ﹤0.01%
24,800
+400
+2% +$1.31K
MWA icon
11234
CALL
Mueller Water Products
MWA
$3.99B
$86.8K ﹤0.01%
4,000
+100
+3% +$2.01K
SLRN
11235
PUT
DELISTED
ACELYRIN
SLRN
$86.8K ﹤0.01%
17,600
+5,000
+40% +$25.8K
GLO
11236
Clough Global Opportunities Fund
GLO
$257M
$86.8K ﹤0.01%
+15,920
New +$84.8K
AIRG icon
11237
PUT
Airgain
AIRG
$72.2M
$86.7K ﹤0.01%
11,500
+11,200
+3,733% +$79.7K
GPRK icon
11238
CALL
GeoPark
GPRK
$615M
$86.6K ﹤0.01%
11,000
+10,600
+2,650% +$97K
RVPH
11239
CALL
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$86.4K ﹤0.01%
3,000
-2,305
-43% -$51.2K
HRTX icon
11240
PUT
Heron Therapeutics
HRTX
$63.9M
$86.4K ﹤0.01%
43,400
+15,200
+54% +$36.3K
PTVE
11241
CALL
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$86.3K ﹤0.01%
7,500
-4,700
-39% -$53.9K
IGMS
11242
PUT
DELISTED
IGM Biosciences
IGMS
$86K ﹤0.01%
5,200
+1,300
+33% +$14.2K
SRTY icon
11243
CALL
ProShares UltraPro Short Russell2000
SRTY
$65.3M
$86K ﹤0.01%
+1,075
New +$99.5K
TACT icon
11244
Transact Technologies
TACT
$53.2M
$85.9K ﹤0.01%
+17,683
New +$73.5K
BCTX
11245
CALL
Briacell Therapeutics
BCTX
$29.9M
$85.9K ﹤0.01%
462
+457
+9,140% +$51.3K
PESI icon
11246
PUT
Perma-Fix Environmental Services
PESI
$369M
$85.9K ﹤0.01%
7,000
-8,200
-54% -$87.7K
HLIO icon
11247
PUT
Helios Technologies
HLIO
$2.69B
$85.9K ﹤0.01%
+1,800
New +$79.1K
SPOK icon
11248
PUT
Spok Holdings
SPOK
$229M
$85.8K ﹤0.01%
5,700
+3,400
+148% +$51.7K
SGMA
11249
DELISTED
Sigmatron International
SGMA
$85.6K ﹤0.01%
30,050
+12,647
+73% +$46.1K
TSI
11250
TCW Strategic Income Fund
TSI
$282M
$85.6K ﹤0.01%
+16,692
New +$83.2K

Similar funds

Citadel Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citadel Advisors's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
  • Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
  • Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
  • Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
  • Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
  • Citadel Advisors opened 1,614 new positions and closed 1,610 in Q3 2024.
  • Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.